Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta
NCT06705751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2026-04-15
Summary
Anomalous aortic origin of the coronary arteries (AAOCA) is a rare congenital disease and one of the leading causes of sudden cardiac deaths (SCD) in young athletes but also has a lethal presentation in adult age with myocardial infarction, even if not related to obstructive coronary arteries. Unfortunately, diagnostic imaging techniques, invasive assessment, and provocative stress tests have shown low sensitivity and specificity in detecting inducible ischemia, and a multimodality assessment is then necessary.
Innovative tools have been developed in the medical field using computer-based simulation, 3-dimensional reconstruction, machine learning, and artificial intelligence (AI). With the application of such new technologies, we aim to fill the gap of knowledge and the diagnostic limitation regarding risk stratification for most subjects with AAOCA.
This work seeks to enhance, fasten, and personalize the clinical diagnosis of AAOCA by integrating anatomical measurements, clinical data, and biomechanical patient-specific features. The SMART study will set a system to automatically segment and classify coronary arteries with AAOCA from computerized tomography angiography (CTA) by artificial intelligence (AI). Segmentation will feed a 3D model of the aortic root and coronary artery for biomechanical assessment through finite element analysis (FEA). This will allow us to assess the location of possible coronary artery compression under an effort condition. These in-silico results, the anatomical features measured by AI, and the clinical data will be integrated into a risk model to estimate the hazard risk of adverse events such as SCD or myocardial infarction. This workflow will be framed in an IT system to allow a web-based remote diagnostic service.
Thanks to the proposed multidisciplinary approach, SMART aims to overcome the current diagnostic limitations related to the reduced ability of functional stress tests to detect ischemia. Potentially helping in patient-specific risk stratification, SMART is also thought to provide a way to get a first diagnostic indication about AAOCA being accessible from any hospital, fostering the diffusion of peripheral territorial support to the diagnosis and treatment of such rare disease.
Conditions
- Myocardial Ischemia
- AAOCA
- ACAOS
- Anomalous Aortic Origin of the Coronary Artery (AAOCA)
- Anomalous Coronary Artery Arising From the Opposite Sinus
- Anomalous Coronary Artery Origin
- Anomalous Coronary Artery With Aortic Origin and Course Between the Great Arteries
- Coronary Anomaly
- Sudden Cardiac Death
- Myocardial Ischemia, Angina Pectoris
Interventions
- DIAGNOSTIC_TEST
-
Autonomic response in AAOCA
Autonomic regulation sub-analysis: Autonomic control will be evaluated in a population prospectively recruited. Thirty-eight subjects with Anomalous Aortic Origin of a Coronary Artery (AAOCA) will undergo an active standing test. For this prospective sample, demographic and clinical data, as well as DICOM images from previously conducted diagnostic CT angiographies (CTAs) for AAOCA, will also be collected. These data will be utilized to assess the final functionality of the online platform before its public launch. The patients will be subjected to the active standing test to elicit an autonomic response, with results compared to reference normal values. During this examination, the following data will be collected: continuous ECG, non-invasive blood pressure, and respiratory measurements in both supine and prone positions.
Sponsors & Collaborators
-
University of Pavia
collaborator OTHER -
University of Naples
collaborator OTHER -
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
collaborator OTHER -
IRCCS Policlinico S. Donato
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-12
- Primary Completion
- 2026-08-31
- Completion
- 2027-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Myocardial Ischemia Without Obstructive Coronary Stenoses
NCT04827498 ·Status: RECRUITING
-
Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia Detection
NCT01374607 ·Status: COMPLETED
-
Coronary Physiology Testing in Acute Coronary Syndromes
NCT04677257 ·Status: COMPLETED ·Phase: NA
-
Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndrome (ACS)
NCT00442949 ·Status: COMPLETED ·Phase: NA
-
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
NCT06860997 ·Status: COMPLETED ·Phase: NA
-
New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography
NCT02240745 ·Status: COMPLETED
-
Comparison of Troponin Assay With New POCT Method in the Decision-making Pathway of Patient With Chest Pain Suspected of Acute Myocardial Ischemia in Emergency Room (POCT)
NCT05764655 ·Status: UNKNOWN
-
Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease
NCT03660969 ·Status: ACTIVE_NOT_RECRUITING
-
Finding Acute Coronary Syndromes (ACS) With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic Symptoms
NCT00880802 ·Status: UNKNOWN
-
Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction
NCT07077057 ·Status: RECRUITING ·Phase: NA
-
MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
NCT06927791 ·Status: RECRUITING
-
The DISCOVER INOCA Prospective Multi-center Registry
NCT05288361 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest Pain (POC Troponina)
NCT06861582 ·Status: RECRUITING ·Phase: NA
-
Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI
NCT00487812 ·Status: COMPLETED ·Phase: NA
-
Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine
NCT06281067 ·Status: RECRUITING ·Phase: NA
-
Identification of Molecular Mechanisms of Coronary Instability in Homogeneous Subsets of Patients With Acute Coronary Syndromes for the Implementation of Precision Medicine
NCT05727982 ·Status: UNKNOWN
-
The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome
NCT04695587 ·Status: UNKNOWN
-
Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes
NCT02126202 ·Status: UNKNOWN ·Phase: PHASE4
-
Artificial Intelligence in ANOCA
NCT06387693 ·Status: RECRUITING ·Phase: NA
-
STable Coronary Artery Diseases RegisTry
NCT03796741 ·Status: COMPLETED
-
Prognostic Value of High Dose Dobutamine Stress Magnetic Resonance Imaging
NCT00837005 ·Status: COMPLETED
-
Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease
NCT06597851 ·Status: RECRUITING ·Phase: NA
-
Vascular Functions in Myeloma Patients During Anti-tumor Therapy
NCT03776331 ·Status: UNKNOWN
-
Risk of Sudden Cardiac Death in UN Athletes
NCT06518252 ·Status: RECRUITING
-
Induced Myocardial Ischemia: a Serial Troponin T and Troponin I Measurements
NCT03203057 ·Status: COMPLETED